Suppr超能文献

血液替代品

Blood substitutes.

作者信息

Moffitt E A

出版信息

Can Anaesth Soc J. 1975 Jan;22(1):12-9. doi: 10.1007/BF03004814.

Abstract

Substitutes for whole blood include blood fractions such as plasma, serum albumin and other fluids of various kinds which are not derived from blood but are used as plasma volume expanders; these, include the usual crystaloid intravenous solutions. Since in comparison to blood far more of these later solutions are given intravenously, a thorough knowledge of plasma volume expanders is essential. The first use of such expanders in human patients was by Hogan in 1915. He used colloidal gelatin and noted an improvement in blood pressure in shock. In 1945, Gronwall and Ingelman advocated the use of dextran in shock. The reguirements for an acceptable plasma substitute are: a satisfactory colloidal osmotic pressure, constand composition at reasonable cost, a viscosity suitable for intravenous administration, stability in prolonged storage at variable temperatures, and sterilization by autoclaving. Such substances must be either fully excreted or metabolized, and must cause no early or late tissue damage. They must be non-antigenic and pyrogen free. They must cause no change in the blood such as haemolysis, R.B.C. agglutination, increased sedimentation rate and no impairment of haemostasis. The presently available plasma expanders include blood derivatives (plasma, albumin), modified protein (gelatin, oxypolygelatin), polymerized carbohydrates (dextran) and plastics (polyvinyl pyrrolidone-PVP). All these substances expand plasma volume, decrease haematocrit and plasma proteins, increase sedimentation rate and blood pressure. Dextran, PVP and geletin do not alter hepatic function. Dextran and gelatin have no deleterious effects on renal function. Features of the clinically used plasma expanders are: 1. Fresh Frozen Plasma Fresh frozen plasma contains all clotting factors except platelets. The risk of the transmission of hepatitis is present as it is with whole blood. 2. Plasma Protein Fractions Plasma protein fractions are free of hepatitis virus, but may cause arteriolar dilatation and hypotension. 3. Serum Albumin Serum albumin is a concentrated blood protein fraction. It is salt poor, stable and does not transmit the virus of hepatitis. Since it has a high oncotic pressure it is necessary to give significant quantities of clear fluids with it. It is expensive, scarce, and dilutes the clotting factors. It is, however, a first choice for emergency treatment of shock; 4. Dextran The dextrans may be of medium or low molecular weight. They are inexpensive and readily available, and do not transmit the virus of hepatitis. In large amounts they cause a coagulation defect and may be antigenic. Continued.

摘要

全血的替代品包括血浆、血清白蛋白等血液成分以及其他各种并非源自血液但用作血浆容量扩充剂的液体;这些包括常用的晶体静脉输液。由于与血液相比,这些后来的溶液静脉输注量要多得多,因此全面了解血浆容量扩充剂至关重要。1915年霍根首次在人类患者中使用此类扩充剂。他使用了胶体明胶,并注意到休克患者的血压有所改善。1945年,格伦瓦尔和英格尔曼主张在休克治疗中使用右旋糖酐。一种可接受的血浆替代品的要求是:具有令人满意的胶体渗透压、成分恒定、成本合理、粘度适合静脉给药、在不同温度下长期储存稳定以及可通过高压灭菌进行消毒。此类物质必须要么完全排泄要么代谢,且不能造成早期或晚期组织损伤。它们必须无抗原性且无热原。它们不能引起血液变化,如溶血、红细胞凝集、沉降率增加以及不影响止血功能。目前可用的血浆扩充剂包括血液衍生物(血浆、白蛋白)、改性蛋白(明胶、氧化聚明胶)、聚合碳水化合物(右旋糖酐)和塑料(聚乙烯吡咯烷酮 - PVP)。所有这些物质都能扩充血浆容量、降低血细胞比容和血浆蛋白、增加沉降率和血压。右旋糖酐、PVP和明胶不改变肝功能。右旋糖酐和明胶对肾功能无不良影响。临床使用的血浆扩充剂的特点如下:1. 新鲜冰冻血浆 新鲜冰冻血浆含有除血小板外的所有凝血因子。与全血一样,存在传播肝炎的风险。2. 血浆蛋白成分 血浆蛋白成分不含肝炎病毒,但可能导致小动脉扩张和低血压。3. 血清白蛋白 血清白蛋白是一种浓缩的血液蛋白成分。它含盐量低、稳定且不传播肝炎病毒。由于其具有高渗透压,因此需要与之同时给予大量的清亮液体。它价格昂贵、稀缺且会稀释凝血因子。然而,它是休克急救治疗的首选;4. 右旋糖酐 右旋糖酐可分为中分子量或低分子量。它们价格便宜且容易获得,并且不传播肝炎病毒。大量使用时会导致凝血缺陷,且可能具有抗原性。续。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验